Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,399 | 223 | 90.4% |
| Travel and Lodging | $251.55 | 1 | 6.7% |
| Education | $108.29 | 3 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,390 | 108 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $497.19 | 9 | $0 (2018) |
| Allergan Inc. | $315.09 | 35 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $203.57 | 8 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $172.42 | 10 | $0 (2017) |
| Janssen Biotech, Inc. | $160.79 | 3 | $0 (2024) |
| Celltrion USA Inc. | $137.50 | 1 | $0 (2024) |
| PFIZER INC. | $129.62 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $129.42 | 9 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $76.10 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $679.27 | 33 | ABBVIE INC. ($210.44) |
| 2023 | $344.08 | 20 | AbbVie Inc. ($50.82) |
| 2022 | $242.75 | 9 | Janssen Biotech, Inc. ($99.95) |
| 2021 | $23.56 | 1 | AbbVie Inc. ($23.56) |
| 2020 | $90.44 | 6 | AbbVie Inc. ($64.92) |
| 2019 | $346.76 | 30 | AbbVie, Inc. ($335.03) |
| 2018 | $696.47 | 62 | AbbVie, Inc. ($328.68) |
| 2017 | $1,336 | 66 | BOSTON SCIENTIFIC CORPORATION ($460.68) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $137.50 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: ANTIBIOTIC | ||||||
| 10/28/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.10 | General |
| 08/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: HEMATOLOGY | ||||||
| 06/27/2024 | Philips North America LLC | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $23.38 | General |
| Category: Medical Device | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Gastroenterology | ||||||
| 06/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Hematology | ||||||
| 05/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | RedHill Biopharma Inc. | Talicia (Drug) | Food and Beverage | Cash or cash equivalent | $13.56 | General |
| Category: Antibiotic | ||||||
| 03/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 392 | 433 | $112,282 | $27,089 |
| 2022 | 2 | 36 | 39 | $5,669 | $2,583 |
| 2020 | 15 | 475 | 538 | $150,591 | $41,035 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 37 | 57 | $9,210 | $3,350 | 36.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 45 | 49 | $11,329 | $2,993 | 26.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 62 | $6,233 | $2,683 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 41 | $6,381 | $2,631 | 41.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 34 | 35 | $14,575 | $2,582 | 17.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 13 | 13 | $9,825 | $2,481 | 25.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $9,076 | $1,790 | 19.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 12 | 12 | $5,631 | $1,761 | 31.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 18 | 18 | $7,585 | $1,383 | 18.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 16 | 16 | $9,701 | $1,379 | 14.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 12 | $6,360 | $1,271 | 20.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $4,589 | $942.36 | 20.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $3,218 | $847.01 | 26.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 12 | 12 | $4,252 | $796.69 | 18.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 57 | 57 | $4,317 | $199.39 | 4.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $3,506 | $1,486 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 15 | $2,163 | $1,097 | 50.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 57 | 96 | $13,712 | $5,353 | 39.0% |
| 45378 | Diagnostic examination of large bowel using an endoscope | Facility | 2020 | 31 | 31 | $17,468 | $4,259 | 24.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 50 | 50 | $20,238 | $3,845 | 19.0% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 35 | 35 | $20,640 | $3,801 | 18.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 36 | 36 | $9,848 | $3,724 | 37.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 44 | 45 | $9,495 | $3,635 | 38.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 18 | 18 | $13,437 | $3,260 | 24.3% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 30 | 31 | $11,918 | $2,398 | 20.1% |
About Dr. Larry Carter, DO
Dr. Larry Carter, DO is a Internal Medicine healthcare provider based in Huntington, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1285954669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larry Carter, DO has received a total of $3,759 in payments from pharmaceutical and medical device companies, with $679.27 received in 2024. These payments were reported across 227 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,399).
As a Medicare-enrolled provider, Carter has provided services to 903 Medicare beneficiaries, totaling 1,010 services with total Medicare billing of $70,707. Data is available for 3 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Gastroenterology
- Location Huntington, WV
- Active Since 06/08/2010
- Last Updated 04/23/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1285954669
Products in Payments
- Humira (Biological) $647.53
- Creon (Drug) $337.30
- GENERAL - BILIARY DEVICES (Device) $260.55
- ZEPATIER (Drug) $203.57
- VIBERZI (Drug) $196.36
- RINVOQ (Biological) $181.88
- SPYGLASS DIRECT VISUALIZATION SYSTEM (Device) $146.24
- VEGZELMA (Biological) $137.50
- STELARA (Biological) $136.80
- XELJANZ (Drug) $129.62
- LINZESS (Drug) $105.78
- XIFAXAN (Drug) $97.68
- APRISO (Drug) $82.28
- Trulance (Drug) $76.10
- HUMIRA (Biological) $75.18
- Talicia (Drug) $69.44
- SKYRIZI (Biological) $68.41
- TRULANCE (Drug) $63.91
- UCERIS (Drug) $57.97
- ZENPEP (Drug) $56.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntington
Aamir Cheema, M.d, M.D
Internal Medicine — Payments: $207,509
Kofi Osei, Md, MD
Internal Medicine — Payments: $78,202
Wesam Frandah, Md, MD
Internal Medicine — Payments: $28,363
Murad Kheetan, Md, MD
Internal Medicine — Payments: $25,358
Rameez Sayyed, Md, MD
Internal Medicine — Payments: $24,444
David Patick, Md, MD
Internal Medicine — Payments: $23,768